BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Espinoza JA, Bizama C, García P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta 2016;1865:245-54. [PMID: 26980625 DOI: 10.1016/j.bbcan.2016.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Koshiol J, Gao YT, Dean M, Egner P, Nepal C, Jones K, Wang B, Rashid A, Luo W, Van Dyke AL, Ferreccio C, Malasky M, Shen MC, Zhu B, Andersen JB, Hildesheim A, Hsing AW, Groopman J. Association of Aflatoxin and Gallbladder Cancer. Gastroenterology 2017;153:488-494.e1. [PMID: 28428144 DOI: 10.1053/j.gastro.2017.04.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
2 Qin Y, Zheng Y, Huang C, Li Y, Gu M, Wu Q. Downregulation of miR-181b-5p Inhibits the Viability, Migration, and Glycolysis of Gallbladder Cancer by Upregulating PDHX Under Hypoxia. Front Oncol 2021;11:683725. [PMID: 34485121 DOI: 10.3389/fonc.2021.683725] [Reference Citation Analysis]
3 Guo R, Qin Y, Shi P, Xie J, Chou M, Chen Y. IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation. Oncol Lett 2016;12:4749-55. [PMID: 28105184 DOI: 10.3892/ol.2016.5254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Dilek ON, Karasu S, Dilek FH. Diagnosis and Treatment of Gallbladder Polyps: Current Perspectives. Euroasian J Hepatogastroenterol 2019;9:40-8. [PMID: 31988866 DOI: 10.5005/jp-journals-10018-1294] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
5 Hu ZI, Lim KH. Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022. Cancers (Basel) 2022;14:1249. [PMID: 35267556 DOI: 10.3390/cancers14051249] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu Z, Alsaggaf R, McGlynn KA, Anderson LA, Tsai HT, Zhu B, Zhu Y, Mbulaiteye SM, Gadalla SM, Koshiol J. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut 2019;68:1458-64. [PMID: 30448774 DOI: 10.1136/gutjnl-2018-317504] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
7 Fluxá P, Rojas-Sepúlveda D, Gleisner MA, Tittarelli A, Villegas P, Tapia L, Rivera MT, López MN, Catán F, Uribe M, Salazar-Onfray F. High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival. BMC Cancer 2018;18:243. [PMID: 29499656 DOI: 10.1186/s12885-018-4147-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
8 Pérez-moreno P, Riquelme I, García P, Brebi P, Roa JC. Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. JPM 2022;12:234. [DOI: 10.3390/jpm12020234] [Reference Citation Analysis]
9 Nemunaitis JM, Brown-Glabeman U, Soares H, Belmonte J, Liem B, Nir I, Phuoc V, Gullapalli RR. Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. BMC Cancer 2018;18:665. [PMID: 29914418 DOI: 10.1186/s12885-018-4575-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
10 Al-Hilu SA, Al-Shujairi WH. Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition. Int J Microbiol 2020;2020:4639761. [PMID: 32908523 DOI: 10.1155/2020/4639761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Nepal C, Zhu B, O'Rourke CJ, Bhatt DK, Lee D, Song L, Wang D, Van Dyke AL, Choo-Wosoba H, Liu Z, Hildesheim A, Goldstein AM, Dean M, LaFuente-Barquero J, Lawrence S, Mutreja K, Olanich ME, Lorenzo Bermejo J, Ferreccio C, Roa JC, Rashid A, Hsing AW, Gao YT, Chanock SJ, Araya JC, Andersen JB, Koshiol J; CGR Exome Studies Group. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. J Hepatol 2021;74:1132-44. [PMID: 33276026 DOI: 10.1016/j.jhep.2020.11.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Elagan SK, Almalki SJ, Alharthi MR, Mohamed MS, El-Badawy MF. Role of Bacteria in the Incidence of Common GIT Cancers: The Dialectical Role of Integrated Bacterial DNA in Human Carcinogenesis. Infect Drug Resist 2021;14:2003-14. [PMID: 34103947 DOI: 10.2147/IDR.S309051] [Reference Citation Analysis]
13 Brägelmann J, Barahona Ponce C, Marcelain K, Roessler S, Goeppert B, Gallegos I, Colombo A, Sanhueza V, Morales E, Rivera MT, de Toro G, Ortega A, Müller B, Gabler F, Scherer D, Waldenberger M, Reischl E, Boekstegers F, Garate-Calderon V, Umu SU, Rounge TB, Popanda O, Lorenzo Bermejo J. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer. Hepatology 2021;73:2293-310. [PMID: 33020926 DOI: 10.1002/hep.31585] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
14 García P, Rosa L, Vargas S, Weber H, Espinoza JA, Suárez F, Romero-Calvo I, Elgueta N, Rivera V, Nervi B, Obreque J, Leal P, Viñuela E, Aguayo G, Muñiz S, Sagredo A, Roa JC, Bizama C. Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer. Cancers (Basel) 2020;12:E778. [PMID: 32218280 DOI: 10.3390/cancers12040778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Horiike M, Morotomi Y, Takemura S, Tanaka S, Shinkawa H, Hashimoto S, Wakasa K, Kubo S. Association between the confluent form of pancreatic and bile duct and histopathological findings in pancreaticobiliary maljunction: A case series study. Ann Med Surg (Lond) 2021;63:102180. [PMID: 33717474 DOI: 10.1016/j.amsu.2021.102180] [Reference Citation Analysis]
16 Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Roa JC, Wang B, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA, Koshiol J. Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer. Sci Rep 2018;8:5671. [PMID: 29618736 DOI: 10.1038/s41598-018-23848-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
17 Koshiol J, Van De Wyngard V, McGee EE, Cook P, Pfeiffer RM, Mardones N, Medina K, Olivo V, Pettit K, Jackson SS, Paredes F, Sanchez R, Huidobro A, Villaseca M, Bellolio E, Losada H, Roa JC, Hildesheim A, Araya JC, Ferreccio C; the Chile BiLS Study Group. The Chile Biliary Longitudinal Study: A Gallstone Cohort. Am J Epidemiol 2021;190:196-206. [PMID: 33524121 DOI: 10.1093/aje/kwaa199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hryciuk B, Pęksa R, Bieńkowski M, Szymanowski B, Radecka B, Winnik K, Żok J, Cichowska N, Iliszko M, Duchnowska R. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer. Sci Rep 2020;10:1871. [PMID: 32024900 DOI: 10.1038/s41598-020-58777-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Riquelme I, Pérez-Moreno P, Letelier P, Brebi P, Roa JC. The Emerging Role of PIWI-Interacting RNAs (piRNAs) in Gastrointestinal Cancers: An Updated Perspective. Cancers (Basel) 2021;14:202. [PMID: 35008366 DOI: 10.3390/cancers14010202] [Reference Citation Analysis]
20 Teng TZJ, Chua BQY, Shelat VG. Carcinosarcoma of gallbladder: A world review. World J Clin Oncol 2021;12:1244-63. [PMID: 35070742 DOI: 10.5306/wjco.v12.i12.1244] [Reference Citation Analysis]
21 Sábato C, Bastos-Rodrigues L, Moraes DC, Friedman E, De Marco L, Resende V. Genetic Analysis of Brazilian Patients with Gallbladder Cancer. Pathol Oncol Res 2019;25:811-4. [PMID: 29552713 DOI: 10.1007/s12253-018-0407-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Malenica I, Donadon M, Lleo A. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine. Cancers (Basel) 2020;12:E2190. [PMID: 32781527 DOI: 10.3390/cancers12082190] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
23 Sharma A, Kumar A, Kumari N, Krishnani N, Rastogi N. Mutational frequency of KRAS, NRAS, IDH2, PIK3CA, and EGFR in North Indian gallbladder cancer patients. Ecancermedicalscience 2017;11:757. [PMID: 28900470 DOI: 10.3332/ecancer.2017.757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
24 Hernández-Luna MA, López-Briones S, Luria-Pérez R. The Four Horsemen in Colon Cancer. J Oncol 2019;2019:5636272. [PMID: 31662752 DOI: 10.1155/2019/5636272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Cheng K, Metry M, Felton J, Shang AC, Drachenberg CB, Xu S, Zhan M, Schumacher J, Guo GL, Polli JE, Raufman JP. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget 2018;9:25572-85. [PMID: 29876009 DOI: 10.18632/oncotarget.25385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
26 Roa JC, Basturk O, Adsay V. Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications. Histopathology 2021;79:2-19. [PMID: 33629395 DOI: 10.1111/his.14360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhou Z, Peng Y, Wu X, Meng S, Yu W, Zhao J, Zhang H, Wang J, Li W. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer. Cell Oncol (Dordr) 2019;42:81-92. [PMID: 30276551 DOI: 10.1007/s13402-018-0410-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
28 Godos J, Micek A, Marranzano M, Salomone F, Rio DD, Ray S. Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Nutrients 2017;9:E950. [PMID: 28846640 DOI: 10.3390/nu9090950] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
29 Sung H, Siegel RL, Torre LA, Pearson‐stuttard J, Islami F, Fedewa SA, Goding Sauer A, Shuval K, Gapstur SM, Jacobs EJ, Giovannucci EL, Jemal A. Global patterns in excess body weight and the associated cancer burden. CA A Cancer J Clin 2018. [DOI: 10.3322/caac.21499] [Cited by in Crossref: 43] [Cited by in F6Publishing: 82] [Article Influence: 10.8] [Reference Citation Analysis]
30 Sharma P, Caldwell TS, Rivera MN, Gullapalli RR. Cadmium exposure activates Akt/ERK Signaling and pro-inflammatory COX-2 expression in human gallbladder epithelial cells via a ROS dependent mechanism. Toxicol In Vitro 2020;67:104912. [PMID: 32512147 DOI: 10.1016/j.tiv.2020.104912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Koshiol J, Gao YT, Corbel A, Kemp TJ, Shen MC, Hildesheim A, Hsing AW, Rashid A, Wang B, Pfeiffer RM, Pinto LA. Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions. Cancer Epidemiol 2018;54:25-30. [PMID: 29554539 DOI: 10.1016/j.canep.2018.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Rosa L, Lobos-González L, Muñoz-Durango N, García P, Bizama C, Gómez N, González X, Wichmann IA, Saavedra N, Guevara F, Villegas J, Arrese M, Ferreccio C, Kalergis AM, Miquel JF, Espinoza JA, Roa JC. Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia. Mol Oncol 2020;14:2834-52. [PMID: 33326125 DOI: 10.1002/1878-0261.12766] [Reference Citation Analysis]
33 Mintz D, Salamon H, Mintz M, Rosenshine I, Shpigel NY. Intraepithelial neutrophils in mammary, urinary and gall bladder infections. Vet Res 2019;50:56. [PMID: 31324217 DOI: 10.1186/s13567-019-0676-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Tounsi N, Djerdjouri B, Bouzid C, Bentabak K. Correlation of adenosine deaminase operating under nitro-oxidative stress with tumor and vascularization in patients with advanced gallbladder carcinoma. J Appl Biomed 2019;17:175-83. [PMID: 34907699 DOI: 10.32725/jab.2019.016] [Reference Citation Analysis]
35 Brun VL, Corbel AF, Hsing AW, Kemp TJ, Van Dyke AL, Hildesheim A, Zhu B, Gao YT, Pinto LA, Koshiol J. Soluble cluster of differentiation 14 levels elevated in bile from gallbladder cancer cases from Shanghai, China. Sci Rep 2021;11:13405. [PMID: 34183723 DOI: 10.1038/s41598-021-92728-5] [Reference Citation Analysis]
36 Qin H, Yuan B, Huang W, Wang Y. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances. Front Oncol 2022;12:924696. [DOI: 10.3389/fonc.2022.924696] [Reference Citation Analysis]
37 Jackson SS, Van De Wyngard V, Pfeiffer RM, Cook P, Hildesheim A, Pinto LA, Jackson SH, Choi K, Verdugo RA, Cuevas M, Yáñez C, Tobar-Calfucoy E, Retamales-Ortega R, Araya JC, Ferreccio C, Koshiol J. Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer. Sci Rep 2021;11:3686. [PMID: 33574564 DOI: 10.1038/s41598-021-83300-2] [Reference Citation Analysis]
38 Villanueva L. Cancer of the gallbladder-Chilean statistics. Ecancermedicalscience 2016;10:704. [PMID: 28105075 DOI: 10.3332/ecancer.2016.704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
39 Jacobs MN, Colacci A, Corvi R, Vaccari M, Aguila MC, Corvaro M, Delrue N, Desaulniers D, Ertych N, Jacobs A, Luijten M, Madia F, Nishikawa A, Ogawa K, Ohmori K, Paparella M, Sharma AK, Vasseur P. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Arch Toxicol 2020;94:2899-923. [PMID: 32594184 DOI: 10.1007/s00204-020-02784-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]